List view / Grid view
26 January 2015 | By Lukats and Shapiro
Doctors fear the wealth of health data from the internet and smartphones could be creating a new army of “worried well”, a survey for the Astellas Innovation DebateTM shows...
26 January 2015 | By NewCap.
Santen SAS announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the granting of a marketing authorization for Ikervis®...
26 January 2015 | By Alliance Pharma plc
Alliance Pharma plc has appointed Nigel Clifford as an independent Non-Executive Director of the Company. Nigel will join the Board with immediate effect.
23 January 2015 | By Novartis
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Jakavi® (ruxolitinib) for the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea...
23 January 2015 | By GlaxoSmithKline
GSK has announced that the first batch of its candidate Ebola vaccine is being shipped to west Africa...
22 January 2015 | By GlobalData
The global therapeutics market for Irritable Bowel Syndrome (IBS) is set to rise in value from $589.6 million in 2013 to $1.5 billion by 2023, representing a high Compound Annual Growth Rate (CAGR) of almost 9.9%, says research and consulting firm GlobalData...
CAMO Software will be exhibiting at the IFPAC® Annual Meeting in Arlington, VA (Washington D.C.) January 25-28. CAMO Software can be found in booth #709...
21 January 2015 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics® Company, and Sunesis Pharmaceuticals have announced the initiation of a clinical mass balance/ADME trial for vosaroxin – a candidate therapeutic for acute myelogenous leukemia (AML)...
21 January 2015 | By Aurora
A once daily injection has been approved for adults with type 2 diabetes and moderate renal impairment (stage 3 chronic kidney disease) in the UK...
21 January 2015 | By Citigate Dewe Rogerson
Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces that its IND for Nefecon® is now open with the US Food & Drug Administration...
21 January 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced a number of leadership changes approved by its board of directors and effective at the close of the annual Shareholders’ Meeting on May 5...
21 January 2015 | By GlobalData
With the US Food and Drug Administration (FDA) approving an all-time record number of orphan drugs during 2014, the pricing of these treatments is set to come under increased scrutiny, says an analyst with research and consulting firm GlobalData...
21 January 2015 | By Distributed by APO (African Press Organization) on behalf of Rotary International
Nigeria marks progress, having gone six months without a case of polio...
20 January 2015 | By Edelman
We believe NPS is a solid acquisition and are confident management can extract significant Revenue and operating synergies, with focus on the 24 Jan FDA action on Natpara...
20 January 2015 | By B3C newswire
TAVIguide™ supports transcatheter aortic valve implantation (TAVI)...
